These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Other 2013-001981-40 Pilot feasibility study of fertility preservation by ovarian stimulation associated with tamoxifen and oocyte or embryo freezing prior chemotherapy for breast cancer. Etude pilote de faisabilité de... not-yet-due
Reported results 2015-004337-27 Evaluation of the impact of a Sandostatin injection before axillary node dissection on lymphorrhea in patients operated for breast cancer Evaluation de l'impact d'une injection de Sandostatine avan... 2018-05-25 due-trials
Not reported 2016-001361-81 Etude diagnostique comparative multicentrique et prospective de la TEP/TDM au 68Ga-HBED-CC-PSMA et des procédures d’imagerie conventionnelle dans le bilan des cancers de prostate en rechute biologiqu... 2023-06-30 due-trials
Reported results 2017-001011-36 Multicentric, comparative, randomized, open study comparing an early post-operative prophylactic non-invasive ventilation (NIV) to standard post-operative care in patients at high-risk of respirator... 2019-10-16 due-trials
Other 2017-003827-31 Prostate cancer with OligometaSTatic relapse: Combining stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736), a randomized phase II trial Cancer prostatique en rechute oligométastatique: as... not-yet-due
Other 2018-002079-17 Evaluation of the 64Cu-ATSM PET-CT as a predictor of the response to neo-adjuvant treatment in locally advanced rectal cancers Evaluation de la TEP-TDM au 64Cu-ATSM comme facteur prédictif de la ré... not-yet-due
Completed, but no date 2018-003559-39 multicentric Study , open, randomized, comparing the topical treatment by patch of capsaïcine with 8 % ( Qutenza) to the oral prégabaline treatment in the early treatment of the neuropathic pains afte... bad-data
Other 2019-001209-26 Multicentre, randomized, controlled, open-label, multi-centre medico-economic study evaluating the efficacy of adding zoledronic acid to Stereotaxic radiotherapy in the treatment of vertebral metastas... not-yet-due
Not reported 2019-001463-75 Pilot Feasibility Study: Inflammation and presence of M2 macrophages explorations with[18F]-DPA-714 PET/CT in Triple Negative breast cancers Étude Pilote de faisabilité : Exploration par TEP/TDM a... 2021-07-21 due-trials
Exempt 2020-001685-11 RElapse in previously irradiated Prostate bed : a phase I/II study of stereotactic Ablative reIRradiation potentiated by Metformine Récidive en loge prostatique déjà irradiée : une étude phase I/II... not-yet-due
Not reported Terminated 2020-003575-18 Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ Impact de l’Hormonothérapie Neoadjuvante sur la prise en charge chirurgicale des carcinomes... 2023-09-26 due-trials
Completed, but no date 2020-003805-71 Prospective phase II pilot study, assessing imaging performance of 89Zirconium-labelled Girentuximab (89Zr-TLX250) PET-CT in metastatic triple negative breast cancer patients OPALESCENCE: zircOn PET-C... bad-data
Other 2021-001017-37 PET-DOPA Metabolic Detection and Characterization of Untreated Brain Metastases of Bronchial, Breast and Melanoma Cancer Détection et Caractérisation Métabolique en TEP-DOPA de Métastases Cérébral... not-yet-due